Next Article in Journal
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
Next Article in Special Issue
A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase
Previous Article in Journal
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands
Previous Article in Special Issue
Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(6), 530; https://doi.org/10.3390/pharmaceutics12060530
Action Date Notes Link
article pdf uploaded. 9 June 2020 12:50 CEST Version of Record https://www.mdpi.com/1999-4923/12/6/530/pdf-vor
article supplementary file uploaded. 9 June 2020 12:50 CEST - https://www.mdpi.com/1999-4923/12/6/530#supplementary
article xml file uploaded 29 June 2020 13:58 CEST Original file -
article xml uploaded. 29 June 2020 13:58 CEST Update https://www.mdpi.com/1999-4923/12/6/530/xml
article pdf uploaded. 29 June 2020 13:58 CEST Updated version of record https://www.mdpi.com/1999-4923/12/6/530/pdf
article html file updated 29 June 2020 13:59 CEST Original file -
article html file updated 6 July 2020 12:30 CEST Update -
article html file updated 21 July 2022 20:20 CEST Update https://www.mdpi.com/1999-4923/12/6/530/html
Back to TopTop